GO:0005488 | binding | 51.72% (45/87) | 1.2 | 0.0 | 1e-06 |
GO:0003723 | RNA binding | 16.09% (14/87) | 2.87 | 0.0 | 2e-06 |
GO:0003676 | nucleic acid binding | 24.14% (21/87) | 1.88 | 0.0 | 1.9e-05 |
GO:0110165 | cellular anatomical entity | 41.38% (36/87) | 1.23 | 0.0 | 1.9e-05 |
GO:0005575 | cellular_component | 44.83% (39/87) | 1.16 | 0.0 | 2.3e-05 |
GO:0003674 | molecular_function | 62.07% (54/87) | 0.81 | 0.0 | 2.8e-05 |
GO:0097159 | organic cyclic compound binding | 35.63% (31/87) | 1.31 | 1e-06 | 4.3e-05 |
GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex | 3.45% (3/87) | 7.47 | 1e-06 | 4.5e-05 |
GO:0005737 | cytoplasm | 14.94% (13/87) | 2.21 | 4e-06 | 0.000209 |
GO:0005829 | cytosol | 10.34% (9/87) | 2.87 | 4e-06 | 0.000231 |
GO:0031072 | heat shock protein binding | 3.45% (3/87) | 5.95 | 1.8e-05 | 0.000756 |
GO:0022627 | cytosolic small ribosomal subunit | 3.45% (3/87) | 5.73 | 2.8e-05 | 0.001088 |
GO:0008150 | biological_process | 48.28% (42/87) | 0.8 | 4e-05 | 0.001465 |
GO:0044391 | ribosomal subunit | 4.6% (4/87) | 4.39 | 4.4e-05 | 0.001486 |
GO:0004815 | aspartate-tRNA ligase activity | 2.3% (2/87) | 7.53 | 5.7e-05 | 0.001688 |
GO:0006422 | aspartyl-tRNA aminoacylation | 2.3% (2/87) | 7.53 | 5.7e-05 | 0.001688 |
GO:0015935 | small ribosomal subunit | 3.45% (3/87) | 5.31 | 6.6e-05 | 0.001841 |
GO:0043228 | non-membrane-bounded organelle | 8.05% (7/87) | 2.69 | 0.000116 | 0.00274 |
GO:0043232 | intracellular non-membrane-bounded organelle | 8.05% (7/87) | 2.69 | 0.000116 | 0.002882 |
GO:0009057 | macromolecule catabolic process | 6.9% (6/87) | 2.93 | 0.000147 | 0.002898 |
GO:0003735 | structural constituent of ribosome | 4.6% (4/87) | 3.99 | 0.00013 | 0.00292 |
GO:0003729 | mRNA binding | 5.75% (5/87) | 3.35 | 0.000142 | 0.002921 |
GO:1990904 | ribonucleoprotein complex | 6.9% (6/87) | 3.01 | 0.000112 | 0.002935 |
GO:0007098 | centrosome cycle | 2.3% (2/87) | 6.8 | 0.000156 | 0.002955 |
GO:0070652 | HAUS complex | 2.3% (2/87) | 6.87 | 0.000141 | 0.003042 |
GO:0005689 | U12-type spliceosomal complex | 2.3% (2/87) | 6.7 | 0.00018 | 0.003268 |
GO:0031023 | microtubule organizing center organization | 2.3% (2/87) | 6.6 | 0.000205 | 0.003339 |
GO:0043226 | organelle | 20.69% (18/87) | 1.34 | 0.000201 | 0.003401 |
GO:0043229 | intracellular organelle | 20.69% (18/87) | 1.34 | 0.000201 | 0.003523 |
GO:0051603 | proteolysis involved in protein catabolic process | 5.75% (5/87) | 3.18 | 0.000245 | 0.003859 |
GO:0003924 | GTPase activity | 4.6% (4/87) | 3.73 | 0.000255 | 0.003896 |
GO:0030544 | Hsp70 protein binding | 2.3% (2/87) | 6.4 | 0.000273 | 0.004031 |
GO:0051254 | positive regulation of RNA metabolic process | 4.6% (4/87) | 3.62 | 0.000338 | 0.004851 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 4.6% (4/87) | 3.54 | 0.000416 | 0.005787 |
GO:0043167 | ion binding | 22.99% (20/87) | 1.16 | 0.000454 | 0.006136 |
GO:0031593 | polyubiquitin modification-dependent protein binding | 2.3% (2/87) | 6.01 | 0.000467 | 0.006138 |
GO:1901564 | organonitrogen compound metabolic process | 19.54% (17/87) | 1.24 | 0.000726 | 0.007156 |
GO:0031331 | positive regulation of cellular catabolic process | 2.3% (2/87) | 5.69 | 0.000723 | 0.007276 |
GO:0061014 | positive regulation of mRNA catabolic process | 2.3% (2/87) | 5.69 | 0.000723 | 0.007276 |
GO:0071826 | protein-RNA complex organization | 3.45% (3/87) | 4.1 | 0.000755 | 0.007293 |
GO:0005198 | structural molecule activity | 4.6% (4/87) | 3.27 | 0.000843 | 0.007386 |
GO:0097526 | spliceosomal tri-snRNP complex | 2.3% (2/87) | 5.85 | 0.000581 | 0.007428 |
GO:0031325 | positive regulation of cellular metabolic process | 4.6% (4/87) | 3.27 | 0.000837 | 0.007468 |
GO:0071010 | prespliceosome | 2.3% (2/87) | 5.59 | 0.000822 | 0.007478 |
GO:0071004 | U2-type prespliceosome | 2.3% (2/87) | 5.59 | 0.000822 | 0.007478 |
GO:1901575 | organic substance catabolic process | 8.05% (7/87) | 2.22 | 0.000795 | 0.007522 |
GO:0022607 | cellular component assembly | 5.75% (5/87) | 2.84 | 0.00072 | 0.007565 |
GO:0043488 | regulation of mRNA stability | 2.3% (2/87) | 5.54 | 0.000886 | 0.007618 |
GO:0000976 | transcription cis-regulatory region binding | 4.6% (4/87) | 3.33 | 0.000714 | 0.007679 |
GO:0001067 | transcription regulatory region nucleic acid binding | 4.6% (4/87) | 3.33 | 0.000714 | 0.007679 |
GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 3.45% (3/87) | 3.98 | 0.00096 | 0.007696 |
GO:0072686 | mitotic spindle | 2.3% (2/87) | 5.49 | 0.000946 | 0.007712 |
GO:0022618 | protein-RNA complex assembly | 3.45% (3/87) | 4.15 | 0.000692 | 0.007798 |
GO:1990837 | sequence-specific double-stranded DNA binding | 4.6% (4/87) | 3.22 | 0.000942 | 0.007821 |
GO:0061013 | regulation of mRNA catabolic process | 2.3% (2/87) | 5.51 | 0.000927 | 0.007834 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 3.45% (3/87) | 3.91 | 0.001096 | 0.007852 |
GO:0004812 | aminoacyl-tRNA ligase activity | 3.45% (3/87) | 3.91 | 0.001096 | 0.007852 |
GO:0019941 | modification-dependent protein catabolic process | 4.6% (4/87) | 3.2 | 0.000996 | 0.007854 |
GO:0061157 | mRNA destabilization | 2.3% (2/87) | 5.73 | 0.000686 | 0.007915 |
GO:0140030 | modification-dependent protein binding | 2.3% (2/87) | 5.73 | 0.000686 | 0.007915 |
GO:0050779 | RNA destabilization | 2.3% (2/87) | 5.73 | 0.000686 | 0.007915 |
GO:0043632 | modification-dependent macromolecule catabolic process | 4.6% (4/87) | 3.14 | 0.00116 | 0.007949 |
GO:0043039 | tRNA aminoacylation | 3.45% (3/87) | 3.89 | 0.001156 | 0.00804 |
GO:0043487 | regulation of RNA stability | 2.3% (2/87) | 5.39 | 0.001091 | 0.00806 |
GO:0000987 | cis-regulatory region sequence-specific DNA binding | 3.45% (3/87) | 3.89 | 0.001149 | 0.00811 |
GO:0006418 | tRNA aminoacylation for protein translation | 3.45% (3/87) | 3.92 | 0.001086 | 0.008157 |
GO:0042026 | protein refolding | 2.3% (2/87) | 5.4 | 0.001078 | 0.008221 |
GO:0009056 | catabolic process | 8.05% (7/87) | 2.15 | 0.00106 | 0.008223 |
GO:0032991 | protein-containing complex | 13.79% (12/87) | 1.57 | 0.000675 | 0.008398 |
GO:0009893 | positive regulation of metabolic process | 4.6% (4/87) | 3.05 | 0.00146 | 0.008422 |
GO:0010468 | regulation of gene expression | 10.34% (9/87) | 1.75 | 0.001482 | 0.008445 |
GO:0043038 | amino acid activation | 3.45% (3/87) | 3.84 | 0.001268 | 0.008445 |
GO:0031903 | microbody membrane | 2.3% (2/87) | 5.2 | 0.001403 | 0.008507 |
GO:0005778 | peroxisomal membrane | 2.3% (2/87) | 5.2 | 0.001403 | 0.008507 |
GO:0010604 | positive regulation of macromolecule metabolic process | 4.6% (4/87) | 3.05 | 0.001457 | 0.008508 |
GO:0006508 | proteolysis | 6.9% (6/87) | 2.28 | 0.00153 | 0.008515 |
GO:0000226 | microtubule cytoskeleton organization | 3.45% (3/87) | 3.73 | 0.001567 | 0.008522 |
GO:0010556 | regulation of macromolecule biosynthetic process | 10.34% (9/87) | 1.74 | 0.001552 | 0.008536 |
GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | 3.45% (3/87) | 3.75 | 0.001517 | 0.00854 |
GO:0016862 | intramolecular oxidoreductase activity, interconverting keto- and enol-groups | 1.15% (1/87) | 9.43 | 0.001447 | 0.008554 |
GO:0050178 | phenylpyruvate tautomerase activity | 1.15% (1/87) | 9.43 | 0.001447 | 0.008554 |
GO:1903313 | positive regulation of mRNA metabolic process | 2.3% (2/87) | 5.28 | 0.001266 | 0.008557 |
GO:0048522 | positive regulation of cellular process | 4.6% (4/87) | 3.09 | 0.00131 | 0.008604 |
GO:0046872 | metal ion binding | 10.34% (9/87) | 1.76 | 0.001389 | 0.008643 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 4.6% (4/87) | 3.07 | 0.001388 | 0.008754 |
GO:0005840 | ribosome | 3.45% (3/87) | 3.8 | 0.001381 | 0.008825 |
GO:0000977 | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3.45% (3/87) | 3.66 | 0.001803 | 0.008886 |
GO:0006082 | organic acid metabolic process | 6.9% (6/87) | 2.24 | 0.001789 | 0.008906 |
GO:0051252 | regulation of RNA metabolic process | 9.2% (8/87) | 1.9 | 0.001378 | 0.008927 |
GO:0043169 | cation binding | 10.34% (9/87) | 1.72 | 0.001665 | 0.008947 |
GO:0043436 | oxoacid metabolic process | 6.9% (6/87) | 2.24 | 0.001782 | 0.008964 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 9.2% (8/87) | 1.85 | 0.001763 | 0.008968 |
GO:0009889 | regulation of biosynthetic process | 10.34% (9/87) | 1.71 | 0.00176 | 0.009047 |
GO:0019752 | carboxylic acid metabolic process | 6.9% (6/87) | 2.24 | 0.001756 | 0.009129 |
GO:0003960 | NADPH:quinone reductase activity | 1.15% (1/87) | 9.05 | 0.00188 | 0.00917 |
GO:0005813 | centrosome | 2.3% (2/87) | 5.05 | 0.001728 | 0.009185 |
GO:0031326 | regulation of cellular biosynthetic process | 10.34% (9/87) | 1.71 | 0.001751 | 0.009202 |
GO:0005875 | microtubule associated complex | 2.3% (2/87) | 4.95 | 0.001972 | 0.009518 |
GO:0004198 | calcium-dependent cysteine-type endopeptidase activity | 1.15% (1/87) | 8.95 | 0.002025 | 0.009675 |
GO:0005815 | microtubule organizing center | 2.3% (2/87) | 4.87 | 0.002213 | 0.010466 |
GO:0051225 | spindle assembly | 2.3% (2/87) | 4.81 | 0.002399 | 0.011237 |
GO:0005684 | U2-type spliceosomal complex | 2.3% (2/87) | 4.79 | 0.002476 | 0.011482 |
GO:0048518 | positive regulation of biological process | 4.6% (4/87) | 2.83 | 0.002519 | 0.011569 |
GO:0051087 | protein-folding chaperone binding | 2.3% (2/87) | 4.73 | 0.002683 | 0.012202 |
GO:0034719 | SMN-Sm protein complex | 1.15% (1/87) | 8.51 | 0.002747 | 0.012259 |
GO:0006357 | regulation of transcription by RNA polymerase II | 4.6% (4/87) | 2.79 | 0.002774 | 0.012263 |
GO:0071013 | catalytic step 2 spliceosome | 2.3% (2/87) | 4.71 | 0.002743 | 0.012359 |
GO:0060255 | regulation of macromolecule metabolic process | 10.34% (9/87) | 1.6 | 0.002859 | 0.012407 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 5.75% (5/87) | 2.38 | 0.002854 | 0.012499 |
GO:0030532 | small nuclear ribonucleoprotein complex | 2.3% (2/87) | 4.62 | 0.003099 | 0.012635 |
GO:0006412 | translation | 3.45% (3/87) | 3.39 | 0.003046 | 0.012638 |
GO:0006807 | nitrogen compound metabolic process | 22.99% (20/87) | 0.93 | 0.003184 | 0.012654 |
GO:0031323 | regulation of cellular metabolic process | 10.34% (9/87) | 1.6 | 0.002976 | 0.012681 |
GO:0005819 | spindle | 2.3% (2/87) | 4.66 | 0.00295 | 0.012685 |
GO:0097525 | spliceosomal snRNP complex | 2.3% (2/87) | 4.62 | 0.003088 | 0.012701 |
GO:0043186 | P granule | 1.15% (1/87) | 8.36 | 0.003036 | 0.012708 |
GO:1990726 | Lsm1-7-Pat1 complex | 1.15% (1/87) | 8.29 | 0.00318 | 0.012748 |
GO:1903311 | regulation of mRNA metabolic process | 2.3% (2/87) | 4.64 | 0.003024 | 0.01277 |
GO:1902494 | catalytic complex | 6.9% (6/87) | 2.07 | 0.003164 | 0.012792 |
GO:0099080 | supramolecular complex | 3.45% (3/87) | 3.35 | 0.003321 | 0.013091 |
GO:0007010 | cytoskeleton organization | 3.45% (3/87) | 3.34 | 0.003408 | 0.013324 |
GO:0019222 | regulation of metabolic process | 10.34% (9/87) | 1.55 | 0.003662 | 0.014199 |
GO:0016462 | pyrophosphatase activity | 5.75% (5/87) | 2.28 | 0.003798 | 0.014257 |
GO:0120114 | Sm-like protein family complex | 2.3% (2/87) | 4.48 | 0.003716 | 0.014291 |
GO:0031329 | regulation of cellular catabolic process | 2.3% (2/87) | 4.47 | 0.003787 | 0.014329 |
GO:0051171 | regulation of nitrogen compound metabolic process | 9.2% (8/87) | 1.67 | 0.003772 | 0.01439 |
GO:0003690 | double-stranded DNA binding | 4.6% (4/87) | 2.65 | 0.003993 | 0.014416 |
GO:0043043 | peptide biosynthetic process | 3.45% (3/87) | 3.27 | 0.003876 | 0.014435 |
GO:0140101 | catalytic activity, acting on a tRNA | 3.45% (3/87) | 3.25 | 0.004049 | 0.014507 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 5.75% (5/87) | 2.26 | 0.00408 | 0.014509 |
GO:0005525 | GTP binding | 3.45% (3/87) | 3.25 | 0.003992 | 0.014525 |
GO:0032561 | guanyl ribonucleotide binding | 3.45% (3/87) | 3.25 | 0.003992 | 0.014525 |
GO:0080090 | regulation of primary metabolic process | 9.2% (8/87) | 1.65 | 0.003991 | 0.014749 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 5.75% (5/87) | 2.25 | 0.004246 | 0.014876 |
GO:0071840 | cellular component organization or biogenesis | 9.2% (8/87) | 1.64 | 0.004235 | 0.014951 |
GO:0019001 | guanyl nucleotide binding | 3.45% (3/87) | 3.21 | 0.004338 | 0.014976 |
GO:0005688 | U6 snRNP | 1.15% (1/87) | 7.85 | 0.004334 | 0.015074 |
GO:0044281 | small molecule metabolic process | 8.05% (7/87) | 1.76 | 0.004766 | 0.016101 |
GO:0006520 | amino acid metabolic process | 4.6% (4/87) | 2.58 | 0.004736 | 0.016115 |
GO:0009896 | positive regulation of catabolic process | 2.3% (2/87) | 4.31 | 0.004721 | 0.016181 |
GO:0007017 | microtubule-based process | 3.45% (3/87) | 3.14 | 0.004999 | 0.01677 |
GO:0140694 | non-membrane-bounded organelle assembly | 2.3% (2/87) | 4.25 | 0.005121 | 0.017059 |
GO:0010005 | cortical microtubule, transverse to long axis | 1.15% (1/87) | 7.58 | 0.005199 | 0.017196 |
GO:0007051 | spindle organization | 2.3% (2/87) | 4.2 | 0.005467 | 0.017956 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.45% (3/87) | 3.03 | 0.00612 | 0.019963 |
GO:0006518 | peptide metabolic process | 3.45% (3/87) | 3.01 | 0.00632 | 0.020475 |
GO:0004450 | isocitrate dehydrogenase (NADP+) activity | 1.15% (1/87) | 7.26 | 0.006494 | 0.020897 |
GO:0034641 | cellular nitrogen compound metabolic process | 12.64% (11/87) | 1.24 | 0.006661 | 0.021146 |
GO:0004420 | hydroxymethylglutaryl-CoA reductase (NADPH) activity | 1.15% (1/87) | 7.23 | 0.006638 | 0.021216 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 3.45% (3/87) | 2.92 | 0.007483 | 0.023596 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3.45% (3/87) | 2.9 | 0.007876 | 0.024673 |
GO:0140535 | intracellular protein-containing complex | 4.6% (4/87) | 2.36 | 0.00794 | 0.024708 |
GO:0043604 | amide biosynthetic process | 3.45% (3/87) | 2.88 | 0.008179 | 0.025287 |
GO:0016043 | cellular component organization | 8.05% (7/87) | 1.6 | 0.00839 | 0.025771 |
GO:0004017 | adenylate kinase activity | 1.15% (1/87) | 6.82 | 0.008793 | 0.026834 |
GO:0140603 | obsolete ATP hydrolysis activity | 1.15% (1/87) | 6.71 | 0.009511 | 0.028837 |
GO:0006399 | tRNA metabolic process | 3.45% (3/87) | 2.78 | 0.009832 | 0.029065 |
GO:0005687 | U4 snRNP | 1.15% (1/87) | 6.67 | 0.009798 | 0.029146 |
GO:0006102 | isocitrate metabolic process | 1.15% (1/87) | 6.67 | 0.009798 | 0.029146 |
GO:0004448 | isocitrate dehydrogenase [NAD(P)+] activity | 1.15% (1/87) | 6.67 | 0.009798 | 0.029146 |
GO:0019773 | proteasome core complex, alpha-subunit complex | 1.15% (1/87) | 6.6 | 0.010228 | 0.029498 |
GO:0004825 | methionine-tRNA ligase activity | 1.15% (1/87) | 6.6 | 0.010228 | 0.029498 |
GO:0006431 | methionyl-tRNA aminoacylation | 1.15% (1/87) | 6.6 | 0.010228 | 0.029498 |
GO:1902652 | secondary alcohol metabolic process | 1.15% (1/87) | 6.58 | 0.010371 | 0.02973 |
GO:0070925 | organelle assembly | 2.3% (2/87) | 3.73 | 0.010193 | 0.029946 |
GO:0001731 | formation of translation preinitiation complex | 1.15% (1/87) | 6.56 | 0.010514 | 0.02996 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 2.3% (2/87) | 3.66 | 0.011201 | 0.031726 |
GO:0070402 | NADPH binding | 1.15% (1/87) | 6.45 | 0.011374 | 0.032022 |
GO:0005874 | microtubule | 2.3% (2/87) | 3.63 | 0.011672 | 0.032667 |
GO:0065003 | protein-containing complex assembly | 3.45% (3/87) | 2.67 | 0.011957 | 0.033075 |
GO:0043565 | sequence-specific DNA binding | 4.6% (4/87) | 2.19 | 0.011907 | 0.033129 |
GO:0009894 | regulation of catabolic process | 2.3% (2/87) | 3.58 | 0.012455 | 0.03425 |
GO:0009987 | cellular process | 28.74% (25/87) | 0.64 | 0.012543 | 0.034294 |
GO:0042579 | microbody | 2.3% (2/87) | 3.56 | 0.012762 | 0.034691 |
GO:0000398 | mRNA splicing, via spliceosome | 2.3% (2/87) | 3.54 | 0.01303 | 0.035219 |
GO:0016034 | maleylacetoacetate isomerase activity | 1.15% (1/87) | 6.21 | 0.013376 | 0.035948 |
GO:0099512 | supramolecular fiber | 2.3% (2/87) | 3.5 | 0.013809 | 0.036489 |
GO:0099081 | supramolecular polymer | 2.3% (2/87) | 3.5 | 0.013809 | 0.036489 |
GO:0043622 | cortical microtubule organization | 1.15% (1/87) | 6.15 | 0.013947 | 0.03665 |
GO:0099513 | polymeric cytoskeletal fiber | 2.3% (2/87) | 3.5 | 0.013745 | 0.036731 |
GO:0005682 | U5 snRNP | 1.15% (1/87) | 6.14 | 0.01409 | 0.036821 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 2.3% (2/87) | 3.46 | 0.014433 | 0.037509 |
GO:0000375 | RNA splicing, via transesterification reactions | 2.3% (2/87) | 3.35 | 0.016745 | 0.043281 |
GO:0017076 | purine nucleotide binding | 13.79% (12/87) | 0.99 | 0.017117 | 0.043765 |
GO:0055028 | cortical microtubule | 1.15% (1/87) | 5.86 | 0.017084 | 0.043916 |
GO:0008152 | metabolic process | 25.29% (22/87) | 0.66 | 0.017721 | 0.045066 |
GO:0043603 | amide metabolic process | 3.45% (3/87) | 2.45 | 0.017819 | 0.045072 |
GO:0004473 | malate dehydrogenase (decarboxylating) (NADP+) activity | 1.15% (1/87) | 5.77 | 0.018222 | 0.045845 |
GO:1902222 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process | 1.15% (1/87) | 5.68 | 0.019358 | 0.04794 |
GO:0006559 | L-phenylalanine catabolic process | 1.15% (1/87) | 5.68 | 0.019358 | 0.04794 |
GO:0005839 | proteasome core complex | 1.15% (1/87) | 5.69 | 0.019216 | 0.048092 |
GO:0016874 | ligase activity | 3.45% (3/87) | 2.39 | 0.019852 | 0.048906 |
GO:0005681 | spliceosomal complex | 2.3% (2/87) | 3.2 | 0.020398 | 0.04948 |
GO:0051879 | Hsp90 protein binding | 1.15% (1/87) | 5.61 | 0.02021 | 0.049531 |
GO:0071704 | organic substance metabolic process | 24.14% (21/87) | 0.66 | 0.020317 | 0.049537 |